ArticleJournal of cancer research and clinical oncology2019

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.

Jun Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.